Victoria A. Johnson

Victoria A. Johnson publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Victoria A. Johnson sits on this spectrum.

Victoria A. Johnson D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Victoria A. Johnson sits on this spectrum.

Best Publications

• Viral dynamics in human immunodeficiency virus type 1 infection

  Xiping Wei;Sajal K. Ghosh;Maria E. Taylor;Victoria A. Johnson

  4345
  Citations

• Update of the Drug Resistance Mutations in HIV-1.

  Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

  1980
  Citations

• 2017 Update of the Drug Resistance Mutations in HIV-1.

  Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  873
  Citations

• 2014 Update of the drug resistance mutations in HIV-1.

  Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson

  841
  Citations

• 2015 Update of the Drug Resistance Mutations in HIV-1.

  Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  766
  Citations

• Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

  M S Hirsch;B Conway;R T D'Aquila;V A Johnson

  741
  Citations

• Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

  Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  674
  Citations

• Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

  Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  664
  Citations

• HIV infection is blocked in vitro by recombinant soluble CD4

  Richard A. Fisher;Jeanne M. Bertonis;Werner Meier;Victoria A. Johnson

  593
  Citations

• Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group.

  A J Japour;D L Mayers;V A Johnson;D R Kuritzkes

  467
  Citations

• Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

  Paul E. Sax;Camlin Tierney;Ann C. Collier;Margaret A. Fischl

  429
  Citations

• Drug Resistance Mutations in HIV-1.

  Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  360
  Citations

• Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection

  Martin S. Hirsch;Scott M. Hammer;Victoria A. Johnson;Daniel R. Kuritzkes

  332
  Citations

• Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

  Ian C. Marschner;Ann C. Collier;Robert W. Coombs;Richard T. D'Aquila

  331
  Citations

• Update of the drug resistance mutations in HIV-1: March 2013.

  Victoria A Johnson;Vincent Calvez;Huldrych F Gunthard;Roger Paredes

  329
  Citations

• Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

  Robert W. Shafer;Laura M. Smeaton;Gregory K. Robbins;Victor De Gruttola

  311
  Citations

• A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

  Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires

  271
  Citations

• Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure

  Roger Paredes;Roger Paredes;Christina M. Lalama;Heather J. Ribaudo;Bruce R. Schackman

  254
  Citations

• Update of the drug resistance mutations in HIV-1: 2007.

  Victoria A Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Huldrych F Günthard

  249
  Citations

• Update of the drug resistance mutations in HIV-1: Fall 2005.

  Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  224
  Citations